Education & Professional Experience

Charlotte has studied at EMLYON Business School in Management de la Technologie et de l'Innovation between 2015 and 2016, then at Université Paris Sud (Paris XI) in Génétique et biologie moélculaire et cellulaire between 2010 and 2013, then at Ecole pratique des Hautes Etudes in Génétique et cancérologie between 2008 and 2010, then at ESTBB - Ecole Supérieure de Biologie - Biochimie - Biotechnologies in Biochimie et biologie moléculaire between 2005 and 2008.

Charlotte worked for Institute for Advanced Biosciences as Chef de projet et chargée de valorisation between Aug 2017 and Dec 2020, for Signia Therapeutics as Business Developer between Apr 2016 and Oct 2016, for EMLYON Business School as Missions réalisées dans le cadre de l'EMLyon between Oct 2015 and Mar 2016, for Centre de Recherche en Cancérologie de Lyon as Chercheur postdoctoral between May 2014 and Aug 2015, for Institut Curie as Etudiante en doctorat between Jan 2012 and Nov 2013, for International Agency for Research on Cancer / World Health Organization as Étudiante between Apr 2008 and Dec 2011, for University College London as Étudiante between May 2007 and Oct 2007.

 Skills & Competences

Charlotte has the following skills : Sequencing, Molecular Cloning, Management de projet, Financement de projet, Molecular Biology, Stratégie de segmentation de clients, Cell Biology, Business plan, Entrepreneuriat, Travail en groupe, Veille technologique, real-time PCR, Business model, Marketing, PCR, Innovation technologique, Marketing de l'innovation, Outils d'innovation, Cell Culture, Gestion de projet.

Charlotte speaks the following languages : English, French.